Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Yeon Ju | - |
dc.contributor.author | Baek, Jin Young | - |
dc.contributor.author | Goo, Jail | - |
dc.contributor.author | Shin, Yoonho | - |
dc.contributor.author | Park, Jong Kuk | - |
dc.contributor.author | Jang, Ji Yong | - |
dc.contributor.author | Wang, Su Bin | - |
dc.contributor.author | Jeong, Woojin | - |
dc.contributor.author | Lee, Hwa Jeong | - |
dc.contributor.author | Um, Hong-Duck | - |
dc.contributor.author | Lee, Sang Kook | - |
dc.contributor.author | Choi, Yongseok | - |
dc.contributor.author | Rhee, Sue Goo | - |
dc.contributor.author | Chang, Tong-Shin | - |
dc.date.accessioned | 2021-09-04T01:44:51Z | - |
dc.date.available | 2021-09-04T01:44:51Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016-03-10 | - |
dc.identifier.issn | 1523-0864 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/89222 | - |
dc.description.abstract | Aims: The intrinsic increase of reactive oxygen species (ROS) production in cancer cells after malignant transformation frequently induces redox adaptation, leading to enhanced antioxidant capacity. Peroxiredoxin I (PrxI), an enzyme responsible for eliminating hydrogen peroxide, has been found to be elevated in many types of cancer cells. Since overexpression of PrxI promoted cancer cells' survival and resistance to chemotherapy and radiotherapy, PrxI has been proposed as a therapeutic target for anticancer drugs. In this study, we aimed to investigate the anticancer efficacy of a small molecule inhibitor of PrxI. Results: By a high-throughput screening approach, we identified AMRI-59 as a potent inhibitor of PrxI. AMRI-59 increased cellular ROS, leading to the activation of both mitochondria- and apoptosis signal-regulated kinase-1-mediated signaling pathways, resulting in apoptosis of A549 human lung adenocarcinoma. AMRI-59 caused no significant changes in ROS level, proliferation, and apoptosis of PrxI-knockdown A549 cells by RNA interference. PrxI overexpression or N-acetylcysteine pretreatment abrogated AMRI-59-induced cytotoxicity in A549 cells. AMRI-59 rendered tumorigenic ovarian cells more susceptible to ROS-mediated death compared with nontumorigenic cells. Moreover, significant antitumor activity of AMRI-59 was observed in mouse tumor xenograft model implanted with A549 cells with no apparent acute toxicity. Innovation: This study offers preclinical proof-of-concept for AMRI-59, a lead small molecule inhibitor of PrxI, as an anticancer agent. Conclusions: Our results highlight a promising strategy for cancer therapy that preferentially eradicates cancer cells by targeting the PrxI-mediated redox-dependent survival pathways. Antioxid. Redox Signal. 27, 453-469. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MARY ANN LIEBERT, INC | - |
dc.subject | CYSTEINE-SULFINIC ACID | - |
dc.subject | CATALASE GENE-EXPRESSION | - |
dc.subject | HYDROGEN-PEROXIDE | - |
dc.subject | LUNG-CANCER | - |
dc.subject | THIOREDOXIN REDUCTASE | - |
dc.subject | MAMMALIAN PEROXIREDOXIN | - |
dc.subject | SIGNAL-TRANSDUCTION | - |
dc.subject | BREAST-CARCINOMA | - |
dc.subject | HEPATOMA-CELLS | - |
dc.subject | SITE CYSTEINE | - |
dc.title | Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, Yongseok | - |
dc.identifier.doi | 10.1089/ars.2014.6187 | - |
dc.identifier.scopusid | 2-s2.0-84962589825 | - |
dc.identifier.wosid | 000372127700004 | - |
dc.identifier.bibliographicCitation | ANTIOXIDANTS & REDOX SIGNALING, v.24, no.8, pp.453 - 469 | - |
dc.relation.isPartOf | ANTIOXIDANTS & REDOX SIGNALING | - |
dc.citation.title | ANTIOXIDANTS & REDOX SIGNALING | - |
dc.citation.volume | 24 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 453 | - |
dc.citation.endPage | 469 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Endocrinology & Metabolism | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Endocrinology & Metabolism | - |
dc.subject.keywordPlus | CYSTEINE-SULFINIC ACID | - |
dc.subject.keywordPlus | CATALASE GENE-EXPRESSION | - |
dc.subject.keywordPlus | HYDROGEN-PEROXIDE | - |
dc.subject.keywordPlus | LUNG-CANCER | - |
dc.subject.keywordPlus | THIOREDOXIN REDUCTASE | - |
dc.subject.keywordPlus | MAMMALIAN PEROXIREDOXIN | - |
dc.subject.keywordPlus | SIGNAL-TRANSDUCTION | - |
dc.subject.keywordPlus | BREAST-CARCINOMA | - |
dc.subject.keywordPlus | SITE CYSTEINE | - |
dc.subject.keywordPlus | HEPATOMA-CELLS | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.